PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-40.99%
Revenue decline while VET shows 25.64% growth. Joel Greenblatt would examine competitive position erosion.
-0.14%
Cost reduction while VET shows 35.40% growth. Joel Greenblatt would examine competitive advantage.
-58.48%
Gross profit decline while VET shows 21.00% growth. Joel Greenblatt would examine competitive position.
-29.64%
Both companies show margin pressure. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
36.11%
G&A growth 50-75% of VET's 62.32%. Bruce Berkowitz would examine operational efficiency.
No Data
No Data available this quarter, please select a different quarter.
29.92%
Other expenses change of 29.92% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
30.54%
Operating expenses growth 1.25-1.5x VET's 22.74%. Martin Whitman would scrutinize control.
15.20%
Total costs growth 50-75% of VET's 27.65%. Bruce Berkowitz would examine efficiency.
-2.38%
Interest expense reduction while VET shows 10.22% growth. Joel Greenblatt would examine advantage.
0.99%
D&A growth less than half of VET's 13.91%. David Dodd would verify if efficiency is sustainable.
-68.61%
EBITDA decline while VET shows 4.45% growth. Joel Greenblatt would examine position.
-45.41%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-125.13%
Operating income decline while VET shows 15.78% growth. Joel Greenblatt would examine position.
-142.58%
Both companies show margin pressure. Martin Whitman would check industry conditions.
202.50%
Other expenses growth above 1.5x VET's 90.88%. Michael Burry would check for concerning trends.
-119.29%
Pre-tax income decline while VET shows 245.09% growth. Joel Greenblatt would examine position.
-132.68%
Pre-tax margin decline while VET shows 174.66% growth. Joel Greenblatt would examine position.
-144.28%
Tax expense reduction while VET shows 2241.68% growth. Joel Greenblatt would examine advantage.
-106.93%
Net income decline while VET shows 77.50% growth. Joel Greenblatt would examine position.
-111.74%
Net margin decline while VET shows 41.27% growth. Joel Greenblatt would examine position.
-107.07%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-107.25%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
No Data
No Data available this quarter, please select a different quarter.
-0.20%
Diluted share reduction while VET shows 8.56% change. Joel Greenblatt would examine strategy.